{
    "2020-02-24": [
        [
            {
                "time": "",
                "original_text": "柳药股份：高溢价“豪赌”存隐忧",
                "features": {
                    "keywords": [
                        "柳药股份",
                        "高溢价",
                        "豪赌",
                        "隐忧"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "别光追爆款，今天介绍一位跑了16年价投马拉松的基金经理",
                "features": {
                    "keywords": [
                        "基金经理",
                        "价投",
                        "马拉松",
                        "16年"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}